Buzzberg Cup Live

SK Hynix ADR Soars.. Semiconductor Shortage Until 2027, Wall Street's Conviction | CEO Lee Kwon-hee

Watch on YouTube ↗  |  July 15, 2026 at 03:00  |  21:45  |  815 Money Talk (815머니톡)
Speakers
Lee Kwon-hee — CEO, Economist

Summary

CEO Lee Kwon-hee analyzes the 27% surge in SK Hynix ADR following a much lower-than-expected US CPI print. He argues that a DRAM shortage driven by HBM demand will last until at least 2027, supporting a long-term bullish view on SK Hynix. The conversation covers Wall Street upgrades, Korea's policy failures, and specific buying opportunities in Alteogen and CMTX.

  • US June CPI came in at 3.5% vs 3.8% expected, sharply reducing rate-hike fears and triggering a strong rally in AI and semiconductor names.
  • SK Hynix ADR jumped 27% partly on options activity; the ~40-50% premium over Korean ordinary shares is expected to converge, making the underlying Korean shares the smarter long-term vehicle.
  • Multiple Wall Street firms project DRAM supply tightness through 2027, with HBM absorbing capacity and keeping memory markets favorable for SK Hynix.
  • The speaker critiques Korean regulators' narrow focus on leverage ETFs and warns that policy missteps risk accelerating outflows to US markets.
  • Alteogen is viewed as oversold; Keytruda SC (Qlex) royalty income and upcoming events create a buy-the-dip opportunity.
  • CMTX, a unique packaging materials supplier, reported strong margins and is positioned for multi-year growth from semiconductor fab expansions.
  • Investors are urged to avoid chasing already-soaring stocks like PSK Holdings and to stick with fundamentally-driven, long-term positions.
Ideas
Lee Kwon-hee CEO, Economist 0:41
HBM-driven DRAM shortage supports long-term SK Hynix upside.
A structural shortage of DRAM — especially HBM — driven by AI server demand will persist at least until 2027, with some analysts extending it into 2028. SK Hynix is a prime beneficiary. Barclays raised its ADR target to $330 based on 8x PER and the supply tightness, while Meritz and Citi echo that HBM will keep memory supply constrained. The SK Hynix ADR surged 27% on global conviction, but the ~40-50% premium over Korean ordinary shares should converge, making the Korean shares the smarter, less leveraged way to ride the long-term uptrend. Buy the underlying (본주) and avoid leveraged products for this secular story.
Lee Kwon-hee CEO, Economist 19:05
Keytruda SC royalties drive Alteogen rebound.
Alteogen was heavily sold off on biosimilar fears, but the panic is overdone. MSD's Qlex (Keytruda SC) delivers a 2% royalty stream, and August 4 earnings should confirm strong Qlex sales, pointing to significant royalty income in the second half. Additional big deal events are expected. The new biosimilar will ultimately prove Alteogen's superiority rather than threaten it. The sharp dip is a buying opportunity.
Lee Kwon-hee CEO, Economist 20:33
Unique packaging materials supplier with strong margins.
CMTX is a unique semiconductor materials supplier to Samsung, SK Hynix, and Micron for advanced packaging processes. It delivered strong Q/Q growth (revenue +11%, operating profit +15%) with an operating margin of 31.8%. With fab expansions continuing, revenue is expected to reach over 1 trillion won by 2027. The recent pullback offers a logical low-price accumulation opportunity.
Up Next

This 815 Money Talk (815머니톡) video, published July 15, 2026, features Lee Kwon-hee discussing 000660.KS, 196170.KQ, CMTX. 3 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Lee Kwon-hee  · Tickers: 000660.KS, 196170.KQ, CMTX